Skip to main content
. 2017 Jan 4;8(8):13166–13173. doi: 10.18632/oncotarget.14486

Table 2. Allele frequencies in cases and controls and odds ratio estimates for CHD.

SNP ID Gene(s) Band Alleles Aa/B MAF HWEp ORs 95% CI p
Case Control
Male
 rs11206831 PPAP2B 1p32.2 T/C 0.050 0.055 1 0.909 0.559-1.478 0.700
 rs1759752 PPAP2B 1p32.2 C/G 0.220 0.168 0.8558 1.401 1.066-1.841 0.015*
 rs1930760 PPAP2B 1p32.2 T/C 0.490 0.467 0.4733 1.093 0.881-1.356 0.418
 rs12566304 PPAP2B 1p32.2 A/C 0.132 0.148 0.1561 0.877 0.643-1.198 0.410
 rs914830 PPAP2B 1p32.2 T/C 0.324 0.329 0.8172 0.976 0.776-1.229 0.838
Female
 rs11206831 PPAP2B 1p32.2 T/C 0.050 0.045 1 1.011 0.530-1.928 0.975
 rs1759752 PPAP2B 1p32.2 C/G 0.209 0.165 1 1.338 0.950-1.883 0.094
 rs1930760 PPAP2B 1p32.2 T/C 0.442 0.498 0.7299 0.799 0.610-1.046 0.102
 rs12566304 PPAP2B 1p32.2 A/C 0.161 0.148 0.1653 1.099 0.759-1.591 0.619
 rs914830 PPAP2B 1p32.2 T/C 0.339 0.348 0.1621 0.961 0.724-1.246 0.784

MAF, minor allelic frequency; HWE, Hardy-Weinberg Equilibrium; ORs, odds ratios; CI: confidence interval.

a Minor allele; *p ≤ 0.05 indicates statistical significance;